GSK expands its state-of-the-art vaccines facility in Singapore with a S$343 million investment

Vaccines |  Company results | By Hithaishi C Bhaskar | 2 Comment | 13 Jul, 2023

GSK Singapore commemorated the groundbreaking ceremony for its S$343 million state-of-the-art vaccines facility at Tuas ...Read more

Sanofi to manufacture and supply vaccines in Saudi Arabia

Vaccines |  News | 0 Comment | 06 Jul, 2023

Lifera, a biopharmaceutical company in Saudi Arabia together with French multinational pharmaceutical and healthcar...Read more

SK bioscience to transfer technology for strengthening vaccine manufacturing in Thailand

Vaccines |  News | 0 Comment | 06 Jul, 2023

South Korea-based biotech firm SK bioscience has signed a Memorandum of Understanding (MoU) with the Government Pha...Read more

Japan approves updated indication for GSK's Shingrix vaccine

Vaccines |  News | 0 Comment | 28 Jun, 2023

British firm GlaxoSmithKline (GSK) has announced that the Japanese Ministry of Health, Labour and Welfare (MHL...Read more

Korea's SK bioscience inks agreement on influenza research with Doherty Institute in Australia

Vaccines |  News | 0 Comment | 28 Jun, 2023

SK bioscience, a global innovative vaccine and biotech company based in South Korea, has signed a collaboratio...Read more

International Vaccine Institute inks new agreement with Seoul National University

Vaccines |  News | 0 Comment | 21 Jun, 2023

The International Vaccine Institute (IVI) and Seoul National University signed an agreement to expand collaboration in r...Read more

Vaxxas opens manufacturing facility in Australia to produce needle-free vaccine patch

Vaccines |  News | 0 Comment | 19 Jun, 2023

Vaxxas, a clinical-stage biotechnology company commercialising a novel vaccination platform technology, has announced th...Read more

Korea-Africa establish new partnership for vaccine R&D and biomanufacturing training

Vaccines |  News | 0 Comment | 14 Jun, 2023

South Korea-based International Vaccine Institute (IVI) and Institut Pasteur de Dakar (IPD) in West Africa, have signed ...Read more

mRNA technology a ‘Game Changer’ for Asia-Pacific vaccine manufacturers: Merck study

Vaccines |  News | 0 Comment | 01 Jun, 2023

According to a recent study sponsored by Merck, a leading science and technology company, mRNA technology is a “ga...Read more

SK bioscience receives marketing authorisation of COVID-19 vaccine in UK

Vaccines |  News | 0 Comment | 31 May, 2023

SK bioscience, based in South Korea, has announced the UK’s Medicines and Healthcare products Regulatory Agency (M...Read more

Devising a viable global strategy to combat Cholera

Vaccines |  Opinion | 0 Comment | 31 May, 2023

For reasons not yet fully understood, beginning in 2022 the world experienced an unprecedented surge in cholera outbreak...Read more

Korea's International Vaccine Institute establishes Joint Research Institution in China

Vaccines |  News | 0 Comment | 23 May, 2023

South Korea-based International Vaccine Institute (IVI) has sigend a Memorandum of Understanding (MoU) with Nankai ...Read more

China approves two COVID-19 vaccine trials against most recent circulating XBB variants

Vaccines |  News | 0 Comment | 22 May, 2023

Recombinant bivalent COVID-19 protein vaccine (Sf9 cells) and recombinant trivalent COVID-19 trimeric protein vaccine (S...Read more

World’s first and only oral cholera vaccine in LDPE unidose pack launches in India

Vaccines |  News | 0 Comment | 12 May, 2023

TechInvention Lifecare in India, has partnered with Eubiologics Co. in  South Korea,  to  launch Euv...Read more

International partnership supports vaccine research to prevent future outbreaks

Vaccines |  News | 0 Comment | 08 May, 2023

Jean-Yves Duclos, Minister of Health, and Harjit S. Sajjan, Minister of International Development and Minister responsib...Read more

Korea begins clinical development of new low-cost oral cholera vaccine in capsule form

Vaccines |  News | 0 Comment | 01 May, 2023

The International Vaccine Institute (IVI), based in South Korea, has begun clinical development of DuoChol, a new low-co...Read more

US FDA approves Pfizer’s 20-valent Pneumococcal Conjugate Vaccine for children

Vaccines |  News | 0 Comment | 28 Apr, 2023

American pharmaceutical firm Pfizer Inc. has announced that the US Food and Drug Administration (FDA) has approved PREVN...Read more

Survey: One-third of COVID-19 vulnerable groups avoid booster shots

Vaccines |  Company results | 2 Comment | 25 Apr, 2023

The results from a new YouGov survey called, ‘What’s Next for COVID-19 in Singapore?’, commissioned by...Read more